Dermatologic Manifestations of the Hypereosinophilic Syndromes

Immunology and Allergy Clinics of North America

Volumn 27, Issue 3, 2007, Pages 415-441

  Leiferman, Kristin M ^a   Gleich, Gerald J ^a   Peters, Margot S ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL PROTEIN; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; ETOPOSIDE; HYDROXYUREA; IMMUNOGLOBULIN; INTERLEUKIN 5; METHOTREXATE; PSORALEN; TIOGUANINE; VINCRISTINE SULFATE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; BLISTER; CHURG STRAUSS SYNDROME; DEGRANULATION; DERMATITIS; DISEASE CLASSIFICATION; EOSINOPHIL; EOSINOPHILIA MYALGIA SYNDROME; FOLLICULITIS; HISTOPATHOLOGY; HUMAN; HYPEREOSINOPHILIC SYNDROME; KIMURA DISEASE; MYELOPROLIFERATIVE DISORDER; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; SKIN DISEASE; SKIN EDEMA; TOXIC OIL SYNDROME; WELLS SYNDROME;

CYTOKINES; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; SKIN; SKIN DISEASES;

EID: 34548506291     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.07.009     Document Type: Review

References (148)

1. Kazmierowski J.A., Chusid M.J., Parrillo J.E., et al. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 114 4 (1978) 531-535
2. van den Hoogenband H.M. Skin lesions as the first manifestation of the hypereosinophilic syndrome. Clin Exp Dermatol 7 3 (1982) 267-271
3. Klion A.D., Bochner B.S., Gleich G.J., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 6 (2006) 1292-1302
4. Kato M., Kephart G.M., Talley N.J., et al. Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 252 3 (1998) 418-425
5. Ackerman S.J., Kephart G.M., Francis H., et al. Eosinophil degranulation. An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol 144 10 (1990) 3961-3969
6. Peters M.S., Schroeter A.L., Kephart G.M., et al. Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol 81 1 (1983) 39-43
7. Kita H., Adolphson C.R., and Gleich G.J. Biology of eosinophils. In: Adkinson N.F., Yunginger J.W., and Busse W.W. (Eds). Middleton's allergy principles and practice. 6th edition (2003), Mosby, Philadelphia 305-332
8. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
9. Dulkys Y., Schramm G., Kimmig D., et al. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils. J Invest Dermatol 116 4 (2001) 498-505
10. Petering H., Kluthe C., Dulkys Y., et al. Characterization of the CC chemokine receptor 3 on human keratinocytes. J Invest Dermatol 116 4 (2001) 549-555
11. Cheng J.F., Ott N.L., Peterson E.A., et al. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 99 5 (1997) 683-692
12. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. N Engl J Med 310 25 (1984) 1621-1626
13. Leiferman K.M., Fujisawa T., Gray B.H., et al. Extracellular deposition of eosinophil and neutrophil granule proteins in the IgE-mediated cutaneous late phase reaction. Lab Invest 62 5 (1990) 579-589
14. Dvorak A.M., Weller P.F., Monahan-Earley R.A., et al. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab Invest 62 5 (1990) 590-607
15. Minnicozzi M., Duran W.N., Gleich G.J., et al. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J Immunol 153 6 (1994) 2664-2670
16. Minnicozzi M., Gleich G.J., Duran W.N., et al. Increased microvascular permeability induced by eosinophil proteins. Int Arch Allergy Immunol 107 1-3 (1995) 348
17. Minnicozzi M., Ramirez M.M., Egan R.W., et al. Polyarginine and eosinophil-derived major basic protein increase microvascular permeability independently of histamine or nitric oxide release. Microvasc Res 50 1 (1995) 56-70
18. Gleich G.J., Loegering D.A., Mann K.G., et al. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest 57 3 (1976) 633-640
19. Leiferman K.M., Loegering D.A., and Gleich G.J. Production of wheal-and-flare skin reactions by eosinophil granule proteins. J Invest Dermatol 82 (1984) 414
20. Patella V., de Crescenzo G., Marino I., et al. Eosinophil granule proteins activate human heart mast cells. J Immunol 157 3 (1996) 1219-1225
21. Okayama Y., el-Lati S.G., Leiferman K.M., et al. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J Allergy Clin Immunol 93 5 (1994) 900-909
22. Piliponsky A.M., Gleich G.J., Nagler A., et al. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101 5 (2003) 1898-1904
23. Davis M.D., Plager D.A., George T.J., et al. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J Allergy Clin Immunol 112 5 (2003) 988-994
24. Leiferman K.M., Peters M.S., and Gleich G.J. The eosinophil and cutaneous edema. J Am Acad Dermatol 15 3 (1986) 513-517
25. Peters M.S., Winkelmann R.K., Greaves M.W., et al. Extracellular deposition of eosinophil granule major basic protein in pressure urticaria. J Am Acad Dermatol 16 3 Pt 1 (1987) 513-517
26. McEvoy M.T., Peterson E.A., Kobza-Black A., et al. Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 133 6 (1995) 853-860
27. Songsiridej V., Peters M.S., Dor P.J., et al. Facial edema and eosinophilia. Evidence for eosinophil degranulation. Ann Intern Med 103 4 (1985) 503-506
28. van Haelst Pisani C., Kovach J.S., Kita H., et al. Administration of interleukin-2 (IL-2) results in increased plasma concentrations of IL-5 and eosinophilia in patients with cancer. Blood 78 6 (1991) 1538-1544
29. Mehregan D.R., Fransway A.F., Edmonson J.H., et al. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dermatol 128 8 (1992) 1055-1059
30. Miljkovic J., and Bartenjev I. Hypereosinophilic dermatitis-like erythema annulare centrifugum in a patient with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 19 2 (2005) 228-231
31. Calux M.J., Valente N.Y., Pires M.C., et al. [Hypereosinophilic syndrome. Cutaneous picture of "erythema annulare centrifugum"-comparison with ultrastructural study]. Med Cutan Ibero Lat Am 16 4 (1988) 299-304
32. Shelley W.B., and Shelley E.D. Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy. Cutis 35 1 (1985) 53-55
33. Jang K.A., Lim Y.S., Choi J.H., et al. Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene. Br J Dermatol 143 3 (2000) 641-644
34. Ohtani T., Okamoto K., Kaminaka C., et al. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 14 3 (2004) 168-171
35. Tsuji Y., Kawashima T., Yokota K., et al. Wells' syndrome as a manifestation of hypereosinophilic syndrome. Br J Dermatol 147 4 (2002) 811-812
36. Bogenrieder T., Griese D.P., Schiffner R., et al. Wells' syndrome associated with idiopathic hypereosinophilic syndrome. Br J Dermatol 137 6 (1997) 978-982
37. Fauci A.S., Harley J.B., Roberts W.C., et al. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97 1 (1982) 78-92
38. Leiferman K.M., and Gleich G.J. Hypereosinophilic syndrome: case presentation and update. J Allergy Clin Immunol 113 1 (2004) 50-58
39. Leiferman K.M., O'Duffy J.D., Perry H.O., et al. Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA 247 7 (1982) 1018-1020
40. Gleich G.J., Leiferman K.M., Pardanani A., et al. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359 9317 (2002) 1577-1578
41. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 13 (2003) 1201-1214
42. Griffin J.H., Leung J., Bruner R.J., et al. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A 100 13 (2003) 7830-7835
43. Klion A.D., Noel P., Akin C., et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101 12 (2003) 4660-4666
44. Simon H.U., Plotz S.G., Dummer R., et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 15 (1999) 1112-1120
45. Roufosse F., Cogan E., and Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 59 7 (2004) 673-689
46. Plotz S.G., Simon H.U., Darsow U., et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349 24 (2003) 2334-2339
47. Hill D.J., Ekert H., and Bryant D.H. Episodic angioedema and hypereosinophilia in childhood. J Allergy Clin Immunol 78 1 Pt 1 (1986) 122-123
48. Katzen D.R., Leiferman K.M., Weller P.F., et al. Hypereosinophilia and recurrent angioneurotic edema in a 2 1/2-year-old girl. Am J Dis Child 140 1 (1986) 62-64
49. Butterfield J.H., Leiferman K.M., Abrams J., et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79 3 (1992) 688-692
50. Putterman C., Barak V., Caraco Y., et al. Episodic angioedema with eosinophilia: a case associated with T cell activation and cytokine production. Ann Allergy 70 3 (1993) 243-248
51. Morgan S.J., Prince H.M., Westerman D.A., et al. Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 44 9 (2003) 1623-1625
52. Butterfield J.H. Diverse clinical outcomes of eosinophilic patients with T-cell receptor gene rearrangements: the emerging diagnostic importance of molecular genetics testing. Am J Hematol 68 2 (2001) 81-86
53. Kawano M., Muramoto H., Tsunoda S., et al. Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia. Am J Hematol 53 1 (1996) 43-45
54. Butterfield J.H., Leiferman K.M., and Gleich G.J. Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy 23 7 (1993) 571-580
55. Zenarola P., Melillo L., Bisceglia M., et al. NERDS syndrome: an additional case report. Dermatology 191 2 (1995) 133-138
56. Churg J., and Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27 2 (1951) 277-301
57. Drage L.A., Davis M.D., De Castro F., et al. Evidence for pathogenic involvementof eosinophils and neutrophilsin Churg-Strauss syndrome. J Am Acad Dermatol 47 2 (2002) 209-216
58. Keogh K.A., and Specks U. Churg-Strauss syndrome. Semin Respir Crit Care Med 27 2 (2006) 148-157
59. Hertzman P.A., Blevins W.L., Mayer J., et al. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 322 13 (1990) 869-873
60. Martin R.W., Duffy J., Engel A.G., et al. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med 113 2 (1990) 124-134
61. Uitto J., Varga J., Peltonen J., et al. Eosinophilia-myalgia syndrome. Int J Dermatol 31 4 (1992) 223-228
62. Martin L.B., Kita H., Leiferman K.M., et al. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 109 3 (1996) 207-215
63. Belongia E.A., Hedberg C.W., Gleich G.J., et al. An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 323 6 (1990) 357-365
64. Mayeno A.N., Belongia E.A., Lin F., et al. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?. Mayo Clin Proc 67 12 (1992) 1134-1139
65. Belongia E.A., Mayeno A.N., and Osterholm M.T. The eosinophilia-myalgia syndrome and tryptophan. Annu Rev Nutr 12 (1992) 235-256
66. Diggle G.E. The toxic oil syndrome: 20 years on. Int J Clin Pract 55 6 (2001) 371-375
67. Ten R.M., Kephart G.M., Posada M., et al. Participation of eosinophils in the toxic oil syndrome. Clin Exp Immunol 82 2 (1990) 313-317
68. Noguchi H., Kephart G.M., Colby T.V., et al. Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol 140 2 (1992) 521-528
69. Antic M., Lautenschlager S., and Itin P.H. Eosinophilic fasciitis 30 years after-what do we really know? Report of 11 patients and review of the literature. Dermatology 213 2 (2006) 93-101
70. Pegorier S., Wagner L.A., Gleich G.J., et al. Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J Immunol 177 7 (2006) 4861-4869
71. Leiferman K.M., Peters M.S., and Gleich G.J. Eosinophils in cutaneous diseases. In: Freedberg I.M., Eisen A.Z., and Wolff K. (Eds). Fitzpatrick's dermatology in general medicine. 6th Edition vol 1 (2003), McGraw-Hill, Inc., New York 959-966
72. Gilliam A.E., Bruckner A.L., Howard R.M., et al. Bullous "cellulitis" with eosinophilia: case report and review of Wells' syndrome in childhood. Pediatrics 116 1 (2005) e149-e155
73. Moossavi M., and Mehregan D.R. Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol 42 1 (2003) 62-67
74. Spigel G.T., and Winkelmann R.K. Wells' syndrome. Recurrent granulomatous dermatitis with eosinophilia. Arch Dermatol 115 5 (1979) 611-613
75. Wells G.C. Recurrent granulomatous dermatitis with eosinophilia. Trans St Johns Hosp Dermatol Soc 57 (1971) 46-56
76. Wells G.C., and Smith N.P. Eosinophilic cellulitis. Br J Dermatol 100 1 (1979) 101-109
77. Schuttelaar M.L., and Jonkman M.F. Bullous eosinophilic cellulitis (Wells' syndrome) associated with Churg-Strauss syndrome. J Eur Acad Dermatol Venereol 17 1 (2003) 91-93
78. Schorr W.F., Tauscheck A.L., Dickson K.B., et al. Eosinophilic cellulitis (Wells' syndrome): histologic and clinical features in arthropod bite reactions. J Am Acad Dermatol 11 6 (1984) 1043-1049
79. Aberer W., Konrad K., and Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 18 1 Pt 1 (1988) 105-114
80. Peters M.S., Schroeter A.L., and Gleich G.J. Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 109 2 (1983) 141-148
81. Brehmer-Andersson E., Kaaman T., Skog E., et al. The histopathogenesis of the flame figure in Wells' syndrome based on five cases. Acta Derm Venereol 66 3 (1986) 213-219
82. Davis M.D., Brown A.C., Blackston R.D., et al. Familial eosinophilic cellulitis, dysmorphic habitus, and mental retardation. J Am Acad Dermatol 38 6 Pt 1 (1998) 919-928
83. Espana A., Sanz M.L., Sola J., et al. Wells' syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin-5. Br J Dermatol 140 1 (1999) 127-130
84. Leiferman K.M., and Peters M.S. Reflections on eosinophils and flame figures: where there's smoke, there's not necessarily Wells' syndrome. Arch Dermatol 142 9 (2006) 1215-1218
85. Melski J.W. Wells' syndrome, insect bites, and eosinophils. Dermatol Clin 8 2 (1990) 287-293
86. Van den Hoogenband H.M. Eosinophilic cellulitis as a result of onchocerciasis. Clin Exp Dermatol 8 (1983) 405-408
87. Hunt S.J., and Santa Cruz D.J. Eosinophilic cellulitis: histologic features in a cutaneous mastocytoma. Dermatologica 182 2 (1991) 132-134
88. Hirsch K., Ludwig R.J., Wolter M., et al. Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma. J Dtsch Dermatol Ges 3 7 (2005) 530-531
89. Nguyen N.Q., and Ma L. Eosinophilic cellulitis and dermographism. Dermatol Online J 11 4 (2005) 7
90. Ludwig R.J., Grundmann-Kollmann M., Holtmeier W., et al. Herpes simplex virus type2-associated eosinophilic cellulitis (Wells' syndrome). J Am Acad Dermatol 48 5 Suppl (2003) S60-S61
91. Beer T.W., Langtry J.A., Phillips W.G., et al. Flame figures in bullous pemphigoid. Dermatology 188 4 (1994) 310-312
92. Rossini M.S., de Souza E.M., Cintra M.L., et al. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol 18 5 (2004) 538-542
93. Winfield H., Lain E., Horn T., et al. Eosinophilic cellulitislike reaction to subcutaneous etanercept injection. Arch Dermatol 142 2 (2006) 218-220
94. Kimura T., Yoshimura S., and Ishikawa E. Unusual granulation combined with hyperplastic changes in lymphatic tissue. Transactions of the Japanese Society of Pathology 13 (1948) 179-180
95. Kung I.T., Gibson J.B., and Bannatyne P.M. Kimura's disease: a clinico-pathological study of 21 cases and its distinction from angiolymphoid hyperplasia with eosinophilia. Pathology 16 1 (1984) 39-44
96. Wang T.F., Liu S.H., Kao C.H., et al. Kimura's disease with generalized lymphadenopathy demonstrated by positron emission tomography scan. Intern Med 45 12 (2006) 775-778
97. Connelly A., Powell H.R., Chan Y.F., et al. Vincristine treatment of nephrotic syndrome complicated by Kimura disease. Pediatr Nephrol 20 4 (2005) 516-518
98. Wells G.C., and Whimster I.W. Subcutaneous angiolymphoid hyperplasia with eosinophilia. Br J Dermatol 81 1 (1969) 1-14
99. Helander S.D., Peters M.S., Kuo T.T., et al. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol 22 4 (1995) 319-326
100. Olsen T.G., and Helwig E.B. Angiolymphoid hyperplasia with eosinophilia. A clinicopathologic study of 116 patients. J Am Acad Dermatol 12 5 Pt 1 (1985) 781-796
101. Chong W.S., Thomas A., and Goh C.L. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two disease entities in the same patient: case report and review of the literature. Int J Dermatol 45 2 (2006) 139-145
102. Nervi S.J., Schwartz R.A., and Dmochowski M. Eosinophilic pustular folliculitis: a 40 year retrospect. J Am Acad Dermatol 55 2 (2006) 285-289
103. Takematsu H., Nakamura K., Igarashi M., et al. Eosinophilic pustular folliculitis. Report of two cases with a review of the Japanese literature. Arch Dermatol 121 7 (1985) 917-920
104. Soeprono F.F., and Schinella R.A. Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. Report of three cases. J Am Acad Dermatol 14 6 (1986) 1020-1022
105. Rajendran P.M., Dolev J.C., Heaphy Jr. M.R., et al. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol 141 10 (2005) 1227-1231
106. Laing M.E., Laing T.A., Mulligan N.J., et al. Eosinophilic pustular folliculitis induced by chemotherapy. J Am Acad Dermatol 54 4 (2006) 729-730
107. Rosenthal D., LeBoit P.E., Klumpp L., et al. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 127 2 (1991) 206-209
108. Ota T., Hata Y., Tanikawa A., et al. Eosinophilic pustular folliculitis (Ofuji's disease): indomethacin as a first choice of treatment. Clin Exp Dermatol 26 2 (2001) 179-181
109. Emmerson R.W., and Wilson-Jones E. Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus. Arch Dermatol 97 3 (1968) 252-257
110. Crotty C., Pittelkow M., and Muller S.A. Eosinophilic spongiosis: a clinicopathologic review of seventy-one cases. J Am Acad Dermatol 8 3 (1983) 337-343
111. Dimson O.G., Giudice G.J., Fu C.L., et al. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 120 5 (2003) 784-788
112. Fairley J.A., Fu C.L., and Giudice G.J. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J Invest Dermatol 125 3 (2005) 467-472
113. Borrego L., Maynard B., Peterson E.A., et al. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins. Am J Pathol 148 3 (1996) 897-909
114. Scheman A.J., Hordinsky M.D., Groth D.W., et al. Evidence for eosinophil degranulation in the pathogenesis of herpes gestationis. Arch Dermatol 125 8 (1989) 1079-1083
115. Thyresson N.H., Goldberg N.C., Tye M.J., et al. Localization of eosinophil granule major basic protein in incontinentia pigmenti. Pediatr Dermatol 8 2 (1991) 102-106
116. Daoud M.S., Su W.P., Leiferman K.M., et al. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 30 6 (1994) 937-943
117. Stahle-Backdahl M., Inoue M., Guidice G.J., et al. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 93 5 (1994) 2022-2030
118. Patterson J.W., Ali M., Murray J.C., et al. Bullous pemphigoid. Occurrence in a patient with mycosis fungoides receiving PUVA and topical nitrogen mustard therapy. Int J Dermatol 24 3 (1985) 173-176
119. Koerber Jr. W.A., Price N.M., and Watson W. Coexistent psoriasis and bullous pemphigoid: a report of six cases. Arch Dermatol 114 11 (1978) 1643-1646
120. Wilczek A., and Sticherling M. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship?. Int J Dermatol 45 11 (2006) 1353-1357
121. Sacher C., Konig C., Scharffetter-Kochanek K., et al. Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea. Dermatology 202 1 (2001) 54-57
122. Kephart G.M., Andrade Z.A., and Gleich G.J. Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue. Am J Pathol 133 2 (1988) 389-396
123. Leiferman K.M., Ackerman S.J., Sampson H.A., et al. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 313 5 (1985) 282-285
124. Kephart G.M., Gleich G.J., Connor D.H., et al. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. Lab Invest 50 1 (1984) 51-61
125. Leiferman K.M. Eosinophils in atopic dermatitis. Allergy 44 Suppl 9 (1989) 20-26
126. Leiferman K.M. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 94 6 Pt 2 (1994) 1310-1317
127. Leiferman K.M. A role for eosinophils in atopic dermatitis. J Am Acad Dermatol 45 1 Suppl (2001) S21-S24
128. Perez G.L., Peters M.S., Reda A.M., et al. Mast cells, neutrophils, and eosinophils in prurigo nodularis. Arch Dermatol 129 7 (1993) 861-865
129. Johansson O., Liang Y., Marcusson J.A., et al. Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis. Arch Dermatol Res 292 8 (2000) 371-378
130. Jacyk W.K., Simson I.W., Slater D.N., et al. Pachydermatous eosinophilic dermatitis. Br J Dermatol 134 3 (1996) 469-474
131. Chan L.S., Robinson N., and Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117 4 (2001) 977-983
132. Fang D., Elly C., Gao B., et al. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nat Immunol 3 3 (2002) 281-287
133. Tsukuba T., Okamoto K., Okamoto Y., et al. Association of cathepsin E deficiency with development of atopic dermatitis. J Biochem (Tokyo) 134 6 (2003) 893-902
134. Yagi R., Nagai H., Iigo Y., et al. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 168 4 (2002) 2020-2027
135. Sasseville D., Wilkinson R.D., and Schnader J.Y. Dermatoses of pregnancy. Int J Dermatol 20 4 (1981) 223-241
136. Ambros-Rudolph C.M., Mullegger R.R., Vaughan-Jones S.A., et al. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 54 3 (2006) 395-404
137. Rudolph C.M., Al-Fares S., Vaughan-Jones S.A., et al. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol 154 1 (2006) 54-60
138. Lawley T.J., Hertz K.C., Wade T.R., et al. Pruritic urticarial papules and plaques of pregnancy. JAMA 241 16 (1979) 1696-1699
139. Spangler A.S., Reddy W., Bardawil W.A., et al. Papular dermatitis of pregnancy. A new clinical entity?. JAMA 181 (1962) 577-581
140. Bierman S.M. Autoimmune progesterone dermatitis of pregnancy. Arch Dermatol 107 6 (1973) 896-901
141. Chen K.R., Pittelkow M.R., Su D., et al. Recurrent cutaneous necrotizing eosinophilic vasculitis. A novel eosinophil-mediated syndrome. Arch Dermatol 130 9 (1994) 1159-1166
142. Chen K.R., Su W.P., Pittelkow M.R., et al. Eosinophilic vasculitis in connective tissue disease. J Am Acad Dermatol 35 2 Pt 1 (1996) 173-182
143. Bahrami S., Malone J.C., Webb K.G., et al. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 142 2 (2006) 155-161
144. Scowden E.B., Schaffner W., and Stone W.J. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 57 6 (1978) 527-544
145. Butterfield J.H. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis. Acta Haematol 114 1 (2005) 26-40
146. Tefferi A. Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 114 1 (2005) 52-60
147. Halaburda K., Prejzner W., Szatkowski D., et al. Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcript. Bone Marrow Transplant 38 4 (2006) 319-320
148. Ueno N.T., Anagnostopoulos A., Rondon G., et al. Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 119 1 (2002) 131-134